Status:
COMPLETED
Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients
Lead Sponsor:
Onze Lieve Vrouwe Gasthuis
Conditions:
Hyperglycaemia
Hypoglycaemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the accuracy and reliability of the continuous glucose monitoring system the FreeStyle Navigator® (Abbott, Diabetes Care) in critically ill patients by compari...
Detailed Description
Most patients admitted to the ICU are treated with intensive insulin therapy, according to a locally developed glucose treatment protocol. The use of a continuous glucose monitoring in critically ill ...
Eligibility Criteria
Inclusion
- ICU-patients \> 18 years
- Expected length of stay on the ICU \> 24 hours
- Indication for glucose regulation with insulin (according to the current glucose treatment protocol)
- Availability of the Freestyle Navigator
Exclusion
- Participation in another trial subject to the WMO
- Lack of informed consent
- Contraindication for the use of the Accu Chek (for example peritoneal dialysis, Ht \<0,20 of \> 0,65; paracetamol intoxication)
- Contraindication for placement of the subcutaneous glucose sensor
- Participation in this trial during previous ICU admittance
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT01526044
Start Date
December 1 2010
End Date
June 1 2012
Last Update
June 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands